Showing results (421-430 of 686) with videos related to
Sort By:
Pageof 69
Seminars in Oncology|October 1, 1994
Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol)J H Beijnen, M T Huizing, W W ten Bokkel Huinink, et al.Cancer Research|March 1, 1992
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavityG Los, O A Smals, M J van Vugt, et al.Cancer Research|June 1, 1989
Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cellsH G Keizer, G J Schuurhuis, H J Broxterman, et al.European Journal of Cancer & Clinical Oncology|April 1, 1982
Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatographyJ Lankelma, P G Penders, J G McVie, et al.Human Gene Therapy|March 17, 2004
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion proteinMichelle de Graaf, Herbert M Pinedo, Dinja Oosterhoff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor modelJ A van Laar, C L van der Wilt, Y M Rustum, et al.Therapeutic Drug Monitoring|January 1, 1986
Pharmacokinetic comparison of cisplatin in solution with common lyophilized cisplatinum (Platinol)J B Vermorken, W J van der Vijgh, I Klein, et al.Nano Letters|January 31, 2008
Single carbon nanotube transistor at GHz frequencyJ Chaste, L Lechner, P Morfin, et al.European Journal of Cancer Care|April 24, 2010
Psychometric properties of the Screening Inventory of Psychosocial Problems (SIPP) in Dutch cancer patients treated with radiotherapyA P B M Braeken, L Lechner, R M A Houben, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenograftsE Boven, M Verschraagen, T M Hulscher, et al.Pageof 69